MA
SRNE

Modus Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Modus Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,706
Closed -$7.09K – 106
2023
Q1 		$7.09K Hold
19,706
– – ﹤0.01% 102
2022
Q4 		$17.5K Hold
19,706
– – 0.01% 100
2022
Q3 		$31K Hold
19,706
– – 0.02% 93
2022
Q2 		$40K Hold
19,706
– – 0.02% 95
2022
Q1 		$46K Hold
19,706
– – 0.02% 97
2021
Q4 		$92K Hold
19,706
– – 0.04% 96
2021
Q3 		$150K Hold
19,706
– – 0.06% 98
2021
Q2 		$191K Hold
19,706
– – 0.08% 97
2021
Q1 		$163K Buy
19,706
+4,846
+33% +$51.2K 0.08% 94
2020
Q4 		$101K Buy
+14,860
New +$119K 0.05% 86
2020
Q3 		– Sell
-10,000
Closed -$63K – 225
2020
Q2 		$63K Buy
+10,000
New +$38.3K 0.04% 108

Other funds holding SRNE

SW
SlateStone Wealth Jupiter, Florida $1.21B AUM 21.86% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.15B AUM 34.45% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
CFGS
Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return